Literature DB >> 408275

Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.

M M Lieberman.   

Abstract

The presence of sugars specific to lipopolysaccharide, glucose, and rhamnose was demonstrated in a Pseudomonas ribosomal vaccine. The detection of these sugars was accomplished by radiological means after paper chromatography of the neutral fraction of acid-hydrolyzed vaccine.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 408275      PMCID： PMC421146          DOI： 10.1128/iai.17.2.471-473.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  27 in total

1.  Biological properties of an immunogenic pneumococcal subcellular preparation.

Authors:  H C Thompson; T K Eisenstein
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

3.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

4.  Immunoprotective activity of ribosomes from Haemophilus influenzae.

Authors:  M Lynn; R P Tewari; M Solotorovsky
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

5.  Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

Authors:  T K Eisenstein
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

6.  Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.

Authors:  I I Andron LA; H T Eigelsbach
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

7.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida.

Authors:  T Baba
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.

Authors:  R L Smith; J A Wysocki; J N Bruun; S J De Courcy; W S Blakemore; S Mudd
Journal:  J Reticuloendothel Soc       Date:  1974-01
View more
  7 in total

1.  Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.

Authors:  B A Green; W Johnson
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

2.  Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.

Authors:  M M Lieberman; D C McKissock; G L Wright
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

4.  Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

5.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.

Authors:  M M Riottot; J M Fournier; H Jouin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.

Authors:  M M Lieberman; G L Wright; K M Wolcott; D C McKissock-Desoto
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.